Hutchmed eyes drug licensing M&A opportunities following HK listing: CEO

Hutchmed's CEO Christian Hogg says the Hong Kong based pharmaceutical company is now 'well capitalized' after its homecoming listing, and outlines what the company plans to do with the funds raised.